Prostate cancer (PC) is one of the most common cancers in males and the fifth leading reason of death. Age, ethnicity, family history, and genetic defects are major factors that determine the aggressiveness and lethality of PC. The African population is at the highest risk of developing high-...
Prostate cancer (PC) is one of the most common cancers in males and the fifth leading reason of death. Age, ethnicity, family history, and genetic defects are major factors that determine the aggressiveness and lethality of PC. The African population is at the highest risk of developing high-...
Context Prostate cancer (PCa) is the second largest male tumor in the world and one of the most common malignant tumors in the urinary system. In recent years, the incidence rate of PCa in China has been increasing year by year. Meanwhile, refractory hormone resistance and adverse drug reacti...
Venook:"In biliary tract cancer, it’s a little different. First of all, for years we had no tissue banks because it’s very hard to collect tissue in these patients. Once we did [collect tissue], we figured out there are a couple of mutations that can be targeted. That’s very ex...
It has been a difficult few months for Britain's royal family. Both Kate, Princess of Wales, and King Charles III have been treated for cancer.
Patients with cancer across the country rely on community oncology practices to provide them with high-quality, coordinated cancer care. John Dodd, director of business and clinical consulting for ION Solutions, a part of Amerisource Bergen John Dodd Patients with cancer across the country rely on...
Combinational therapy with conventional antagonists and coactivator antagonists may provide novel therapeutic strategies to treat castration‐resistant prostate cancer in the near future.doi:10.1080/08940880008261056Walker, Richard P.Diviacco, BrunoTaylor & Francis GroupSynchrotron Radiation News...
Expression of NUAK2 in gastric cancer tissue and its effects on the proliferation of gastric cancer cells. Exp. Ther. Med. 13, 676 (2017). CAS PubMed Google Scholar Fu, W. et al. NUAK family kinase 2 is a novel therapeutic target for prostate cancer. Mol. Carcinog. 61, 334–345 ...
Creating fast, non-invasive, precise, and specific diagnostic tests is crucial for enhancing cancer treatment outcomes. Among diagnostic methods, those relying on nucleic acid detection are highly sensitive and specific. Recent developments in diagnostic
(a by-product of glycine synthesis and breakdown), was detected usingTi3C2TX (where T = terminal groups i.e. = O, -OH, and -F) biosensor (Fig.25). For the first time, it is being evaluated in urine as a possible glandular prostate cancer biomarker (Hroncekova et al.2020...